Form 4: Nuvalent Director Matthew Shair Sells Shares Under 10b5-1 Trading Plan

Director Matthew Shair sold shares of Nuvalent, Inc. (NUVL) on August 26, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On August 26, 2024, Matthew Shair, a director of Nuvalent, Inc., sold shares of Class A Common Stock.
• The sales were executed under a Rule 10b5-1 trading plan adopted on December 21, 2023.
• The transactions involved multiple sales at varying prices.
• Shair sold 797 shares at a weighted average price of $83.81, 1,047 shares at $84.79, and 156 shares at $85.53.
• Following these transactions, Shair directly owns 1,427,197 shares and indirectly owns 228,522 shares through the Matthew D. Shair 2021 Irrevocable Family Trust.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock sales by a director. It doesn't inherently convey positive or negative sentiment, as it's a routine disclosure.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It's common for executives and directors to use 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.

Key Dates